321(top 100%)
papers
15.9K(top 1%)
citations
63(top 100%)
h-index
117(top 100%)
g-index
436
all documents
17.2K
doc citations
2.7K
citing journals
100
times ranked

Publications

348 papers • 17,193 citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
Journal of Clinical Oncology, 2025, 43, 422-431
17.11Citations (PDF)
2Physical Activity during Adolescence and Early Adulthood and Breast Cancer Risk before Age 40 Years0.90Citations (PDF)
3Childhood physical activity and pubertal timing: findings from the LEGACY girls study5.20Citations (PDF)
4Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk5.22Citations (PDF)
5Dietary Factors and Early-Onset Colorectal Cancer in the United States—an Ecologic Analysis0.911Citations (PDF)
6Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry0.96Citations (PDF)
7Socioeconomic Status at Birth and Breast Tissue Composition in Adolescence and Adulthood0.90Citations (PDF)
8Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education
Journal of Clinical Oncology, 2023, 41, 4905-4915
17.12Citations (PDF)
9A Clinical Risk Model for Surgical Site Infection Following Pediatric Spine Deformity Surgery3.618Citations (PDF)
10Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants
Genetics in Medicine, 2022, 24, 119-129
2.316Citations (PDF)
11Predictors of urinary polycyclic aromatic hydrocarbon metabolites in girls from the San Francisco Bay Area
Environmental Research, 2022, 205, 112534
8.04Citations (PDF)
12Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use
Cancer Causes and Control, 2022, 33, 363-371
1.80Citations (PDF)
13Cancer Risks Associated With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants
Journal of Clinical Oncology, 2022, 40, 1529-1541
17.1154Citations (PDF)
14Rare germline copy number variants (CNVs) and breast cancer risk4.511Citations (PDF)
15Polygenic risk modeling for prediction of epithelial ovarian cancer risk3.132Citations (PDF)
16Common variants in breast cancer risk loci predispose to distinct tumor subtypes5.018Citations (PDF)
17Oral Contraceptive Use in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Absolute Cancer Risks and Benefits5.112Citations (PDF)
18OUP accepted manuscript5.20Citations (PDF)
19Improvement on recovery and reproducibility for quantifying urinary mono-hydroxylated polycyclic aromatic hydrocarbons (OH-PAHs)2.65Citations (PDF)
20Do current family history-based genetic testing guidelines contribute to breast cancer health inequities?6.810Citations (PDF)
21Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)
Cancer Prevention Research, 2022, 15, 185-191
1.15Citations (PDF)
22Air Pollution and Breast Cancer: An Examination of Modification By Underlying Familial Breast Cancer Risk0.914Citations (PDF)
23The Epidemiology of Pregnancy-Related Breast Cancers: Are We Ready to Deliver?0.91Citations (PDF)
24Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer Risk
Journal of Pediatrics, 2022, 251, 113-119.e7
2.14Citations (PDF)
25Exposure to polycyclic aromatic hydrocarbons during pregnancy and breast tissue composition in adolescent daughters and their mothers: a prospective cohort study5.07Citations (PDF)
26Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations2.51Citations (PDF)
27Cancer Education Interventions in Adolescents: A Systematic Review of Scope and Content
Health Education and Behavior, 2022, 49, 993-1003
1.92Citations (PDF)
28Common Childhood Viruses and Pubertal Timing: The LEGACY Girls Study3.63Citations (PDF)
29Prepubertal Internalizing Symptoms and Timing of Puberty Onset in Girls3.614Citations (PDF)
30Associations of prenatal exposure to polycyclic aromatic hydrocarbons with pubertal timing and body composition in adolescent girls: Implications for breast cancer risk
Environmental Research, 2021, 196, 110369
8.019Citations (PDF)
31Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort5.113Citations (PDF)
32The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids0.911Citations (PDF)
33Cancer Risk Reduction Through Education of Adolescents: Development of a Tailored Cancer Risk-Reduction Educational Tool1.05Citations (PDF)
34DNA methylation and cancer incidence: lymphatic–hematopoietic versus solid cancers in the Strong Heart Study4.311Citations (PDF)
35Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants
JAMA Oncology, 2021, ,
13.616Citations (PDF)
36Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models3.220Citations (PDF)
37Long-term PM2.5 exposure before diagnosis is associated with worse outcome in breast cancer2.513Citations (PDF)
38Breast Tissue Composition—Why It Matters and How Can We Measure It More Accurately in Epidemiology Studies0.93Citations (PDF)
39Less Is More—Ways to Move Forward for Improved Breast Cancer Risk Stratification0.94Citations (PDF)
40Symposium report: breast cancer in India—trends, environmental exposures and clinical implications
Cancer Causes and Control, 2021, 32, 567-575
1.813Citations (PDF)
41Benign breast disease and changes in mammographic breast density5.03Citations (PDF)
42Prenatal polycyclic aromatic hydrocarbons, altered ERα pathway-related methylation and expression, and mammary epithelial cell proliferation in offspring and grandoffspring adult mice
Environmental Research, 2021, 196, 110961
8.014Citations (PDF)
43Alcohol, Binge Drinking, and Cancer Risk: Accelerating Public Health Messaging Through Countermarketing3.310Citations (PDF)
44Effects of fertility on breast cancer incidence trends: comparing France and US
Cancer Causes and Control, 2021, 32, 903-910
1.84Citations (PDF)
45A competing risks model with binary time varying covariates for estimation of breast cancer risks in <i>BRCA1</i> families1.72Citations (PDF)
46Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element6.84Citations (PDF)
47Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study2.539Citations (PDF)
48Is it ‘cancer prevention’ or ‘risk reduction’? #Wordsmatter
Cancer Causes and Control, 2021, 32, 919-922
1.80Citations (PDF)
49Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment5.08Citations (PDF)
50Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry
JAMA Network Open, 2021, 4, e2119084
7.235Citations (PDF)
51E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk
Journal of Community Health, 2021, 47, 94-100
1.94Citations (PDF)
52Reproductive and environmental exposures and the breast cancer risk in Taiwanese women
Scientific Reports, 2021, 11,
3.75Citations (PDF)
53Mendelian randomisation study of smoking exposure in relation to breast cancer risk
British Journal of Cancer, 2021, 125, 1135-1145
5.712Citations (PDF)
54Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns
EClinicalMedicine, 2021, 38, 100985
8.8148Citations (PDF)
55Breast Density Awareness and Knowledge in a Mammography Screening Cohort of Predominantly Hispanic Women: Does Breast Density Notification Matter?0.912Citations (PDF)
56Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer5.02Citations (PDF)
57Age-specific Trends in Colorectal Cancer Incidence for Women and Men, 1935–2017
Gastroenterology, 2021, 161, 1060-1062.e3
1.013Citations (PDF)
58Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline <i>BRCA1</i> or <i>BRCA2</i> Pathogenic Variants—Caution Needed—Reply
JAMA Oncology, 2021, 7, 1402
13.624Citations (PDF)
59Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models
Cancers, 2021, 13, 5194
4.07Citations (PDF)
60Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk3.24Citations (PDF)
61DDT exposure during pregnancy and DNA methylation alterations in female offspring in the Child Health and Development Study
Reproductive Toxicology, 2020, 92, 138-147
2.914Citations (PDF)
62Body size at birth, early-life growth and the timing of the menopausal transition and natural menopause
Reproductive Toxicology, 2020, 92, 91-97
2.95Citations (PDF)
63Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation Results5.11Citations (PDF)
64Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk
Cancer Research, 2020, 80, 116-125
0.642Citations (PDF)
65In utero DDT exposure and breast density in early menopause by maternal history of breast cancer
Reproductive Toxicology, 2020, 92, 78-84
2.916Citations (PDF)
66Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, 2020, 52, 56-73
16.3116Citations (PDF)
67Commentary: No multiplicative GXE interactions for breast cancer risk: Have we reached a verdict or is the jury still out?5.22Citations (PDF)
68Placental morphometry in relation to daughters’ percent mammographic breast density at midlife
Reproductive Toxicology, 2020, 92, 98-104
2.92Citations (PDF)
69In utero DDT exposure and breast density before age 50
Reproductive Toxicology, 2020, 92, 85-90
2.920Citations (PDF)
70Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research3.123Citations (PDF)
71Influence of pubertal development on urinary oxidative stress biomarkers in adolescent girls in the New York LEGACY cohort
Free Radical Research, 2020, 54, 431-441
2.97Citations (PDF)
72Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016
JAMA Network Open, 2020, 3, e2013226
7.2105Citations (PDF)
73Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk6.843Citations (PDF)
74Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density5.07Citations (PDF)
75Reducing Breast Cancer Risk Across Generations Through Family-Based Interventions3.31Citations (PDF)
76Editorial: Perspectives in Primary Prevention Research for Breast Cancer: A Focus on Gene—Environment Interactions2.71Citations (PDF)
77Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort5.09Citations (PDF)
78Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015
JAMA Network Open, 2020, 3, e200929
7.230Citations (PDF)
79Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature
Environmental Research, 2020, 187, 109346
8.038Citations (PDF)
80Do Temporal Trends in Cancer Incidence Reveal Organ System Connections for Cancer Etiology?
Epidemiology, 2020, 31, 595-598
3.13Citations (PDF)
81Urinary Estrogen Metabolites and Long-Term Mortality Following Breast Cancer3.20Citations (PDF)
82Symptoms and demographic factors associated with early-onset colorectal neoplasia among individuals undergoing diagnostic colonoscopy1.410Citations (PDF)
83Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Scientific Reports, 2020, 10,
3.73Citations (PDF)
84Characterization of the Cancer Spectrum in Men With Germline<i>BRCA1</i>and<i>BRCA2</i>Pathogenic Variants
JAMA Oncology, 2020, 6, 1218
13.648Citations (PDF)
85Menopausal hormone therapy use and long‐term all‐cause and cause‐specific mortality in the Long Island Breast Cancer Study Project
International Journal of Cancer, 2020, 147, 3404-3415
4.54Citations (PDF)
86Survival model methods for analyses of cancer incidence trends in young adults
Statistics in Medicine, 2020, 39, 1011-1024
1.76Citations (PDF)
87Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer
British Journal of Cancer, 2020, 122, 1133-1140
5.719Citations (PDF)
88Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
Genetic Epidemiology, 2020, 44, 442-468
3.230Citations (PDF)
89Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium0.927Citations (PDF)
90A network analysis to identify mediators of germline-driven differences in breast cancer prognosis14.131Citations (PDF)
91Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers5.045Citations (PDF)
92Translate but validate: necessary steps in improving the use and utility of cancer risk models
Cancer Causes and Control, 2020, 31, 537-540
1.81Citations (PDF)
93Associations of Nativity, Age at Migration, and Percent of Life in the U.S. with Midlife Body Mass Index and Waist Size in New York City Latinas3.15Citations (PDF)
94Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients
Clinical Trials, 2020, 17, 184-194
2.223Citations (PDF)
95Response to ten Broeke et al.
Genetics in Medicine, 2019, 21, 258-259
2.32Citations (PDF)
9640 Years of Change in Age- and Stage-Specific Cancer Incidence Rates in US Women and Men3.266Citations (PDF)
97Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population‐based study
Cancer, 2019, 125, 3836-3844
4.413Citations (PDF)
98Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy3.719Citations (PDF)
99The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer6.830Citations (PDF)
100Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool3.29Citations (PDF)
101Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research5.0152Citations (PDF)
102Two truncating variants in FANCC and breast cancer risk3.76Citations (PDF)
103Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention1.310Citations (PDF)
104Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer
BMC Cancer, 2019, 19,
3.05Citations (PDF)
105Shared heritability and functional enrichment across six solid cancers14.175Citations (PDF)
106Early-Life Growth and Benign Breast Disease
American Journal of Epidemiology, 2019, 188, 1646-1654
3.65Citations (PDF)
107Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
British Journal of Cancer, 2019, 121, 180-192
5.715Citations (PDF)
108Performance of BCRAT in high-risk patients with breast cancer – Authors' reply
Lancet Oncology, The, 2019, 20, e286
21.93Citations (PDF)
109Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)
Cancer Prevention Research, 2019, 12, 481-490
1.115Citations (PDF)
110Applications for Quantile Regression in Epidemiology3.328Citations (PDF)
111Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study5.046Citations (PDF)
112Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer14.183Citations (PDF)
113Genome-wide association study of germline variants and breast cancer-specific mortality
British Journal of Cancer, 2019, 120, 647-657
5.745Citations (PDF)
114Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer
JAMA Network Open, 2019, 2, e190083
7.211Citations (PDF)
115Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort4.510Citations (PDF)
116Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis
International Journal of Cancer, 2019, 145, 3207-3217
4.516Citations (PDF)
117Response to Wang et al.
Genetics in Medicine, 2019, 21, 2158
2.30Citations (PDF)
11810-year performance of four models of breast cancer risk: a validation study
Lancet Oncology, The, 2019, 20, 504-517
21.9119Citations (PDF)
119DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows5.186Citations (PDF)
120Response to Lee et al 2019: Essential to frame study implications within the context of prior findings from enriched cohorts for underlying familial risk of breast cancer2.71Citations (PDF)
121Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)5.038Citations (PDF)
122Environmental Influences on Mammographic Breast Density in California: A Strategy to Reduce Breast Cancer Risk3.16Citations (PDF)
123Response to Evans et al.
Genetics in Medicine, 2019, 21, 1880-1881
2.31Citations (PDF)
124Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes6.8684Citations (PDF)
125Do Birth Weight and Weight Gain During Infancy and Early Childhood Explain Variation in Mammographic Density in Women in Midlife? Results From Cohort and Sibling Analyses3.67Citations (PDF)
126Height and Body Mass Index as Modifiers of Breast Cancer Risk in <i>BRCA1</i>/<i>2</i> Mutation Carriers: A Mendelian Randomization Study5.128Citations (PDF)
127Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk5.135Citations (PDF)
128Pre-diagnostic aspirin use and mortality after breast cancer
Cancer Causes and Control, 2018, 29, 417-425
1.88Citations (PDF)
129Why do studies show different associations between intrauterine exposure to maternal smoking and age at menarche?
Annals of Epidemiology, 2018, 28, 197-203
1.79Citations (PDF)
130Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations
Human Mutation, 2018, 39, 593-620
4.1226Citations (PDF)
131Breast cancer family history and allele-specific DNA methylation in the legacy girls study
Epigenetics, 2018, 13, 240-250
3.311Citations (PDF)
132MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer
Genetics in Medicine, 2018, 20, 1167-1174
2.3122Citations (PDF)
133Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer5.010Citations (PDF)
134Maternal cigarette smoking during pregnancy and offspring DNA methylation in midlife
Epigenetics, 2018, 13, 129-134
3.346Citations (PDF)
135Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies?4.663Citations (PDF)
136The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations3.223Citations (PDF)
137Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)5.057Citations (PDF)
138Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study3.235Citations (PDF)
139Childhood body size and midlife mammographic breast density in foreign-born and U.S.-born women in New York City
Annals of Epidemiology, 2018, 28, 710-716
1.77Citations (PDF)
140RE: “GROWTH TRAJECTORIES, BREAST SIZE, AND BREAST-TISSUE COMPOSITION IN A BRITISH PREBIRTH COHORT OF YOUNG WOMEN”
American Journal of Epidemiology, 2018, 187, 2069-2069
3.61Citations (PDF)
141Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy1.916Citations (PDF)
142Hair product use, age at menarche and mammographic breast density in multiethnic urban women5.680Citations (PDF)
143A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Nature Genetics, 2018, 50, 968-978
16.3160Citations (PDF)
144Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer0.910Citations (PDF)
145Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ
British Journal of Cancer, 2018, 119, 36-39
5.713Citations (PDF)
146Assessing patient readiness for personalized genomic medicine1.210Citations (PDF)
147Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab
Genetics in Medicine, 2017, 19, 30-35
2.346Citations (PDF)
148Early life socioeconomic environment and mammographic breast density
BMC Cancer, 2017, 17,
3.08Citations (PDF)
149Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes5.020Citations (PDF)
150Earlier age at menarche in girls with rapid early life growth: cohort and within sibling analyses
Annals of Epidemiology, 2017, 27, 187-193.e2
1.721Citations (PDF)
151Dietary isoflavone intake and all‐cause mortality in breast cancer survivors: The Breast Cancer Family Registry
Cancer, 2017, 123, 2070-2079
4.472Citations (PDF)
152Age-Specific Indicators of a Healthy Lifestyle and Postmenopausal Breast Cancer
Journal of Women's Health, 2017, 26, 1176-1184
2.24Citations (PDF)
153Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction2.54Citations (PDF)
154Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers13.72,005Citations (PDF)
155Genetic–epigenetic interactions in cis: a major focus in the post-GWAS era
Genome Biology, 2017, 18,
8.499Citations (PDF)
156Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease1.819Citations (PDF)
157Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer
British Journal of Cancer, 2017, 116, 1229-1233
5.755Citations (PDF)
158Using time-varying quantile regression approaches to model the influence of prenatal and infant exposures on childhood growth0.42Citations (PDF)
159Association analysis identifies 65 new breast cancer risk loci
Nature, 2017, 551, 92-94
40.1983Citations (PDF)
160Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer3.65Citations (PDF)
161Non-invasive optical spectroscopic monitoring of breast development during puberty5.014Citations (PDF)
162Pubertal development in girls by breast cancer family history: the LEGACY girls cohort5.017Citations (PDF)
163Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers5.1217Citations (PDF)
164Maternal and Early Childhood Determinants of Women's Body Size in Midlife: Overall Cohort and Sibling Analyses3.69Citations (PDF)
165Consistency, now what?5.09Citations (PDF)
166Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry
PLoS ONE, 2017, 12, e0189118
2.511Citations (PDF)
167DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry
Anticancer Research, 2017, 37, 659-664
1.25Citations (PDF)
168Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS ONE, 2016, 11, e0158801
2.59Citations (PDF)
169The LEGACY Girls Study
Epidemiology, 2016, 27, 438-448
3.125Citations (PDF)
170Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus5.029Citations (PDF)
171Potential Intervention Targets in Utero and Early Life for Prevention of Hormone Related Cancers
Pediatrics, 2016, 138, S22-S33
4.18Citations (PDF)
172Maternal Anthropometry and Mammographic Density in Adult Daughters
Pediatrics, 2016, 138, S34-S41
4.15Citations (PDF)
173Family-based Breast Cancer Prevention Efforts in Adolescence
Pediatrics, 2016, 138, S78-S80
4.18Citations (PDF)
174Empowering Pediatricians to Prevent Chronic Disease Across Generations
Pediatrics, 2016, 138, S92-S94
4.18Citations (PDF)
175Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/25.082Citations (PDF)
176Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour2.57Citations (PDF)
177Early life growth, socioeconomic status, and mammographic breast density in an urban US birth cohort
Annals of Epidemiology, 2016, 26, 540-545.e2
1.715Citations (PDF)
178Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women5.053Citations (PDF)
179Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus14.165Citations (PDF)
180Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)5.252Citations (PDF)
181Comparison of Clinical, Maternal, and Self Pubertal Assessments: Implications for Health Studies
Pediatrics, 2016, 138,
4.136Citations (PDF)
182Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry0.988Citations (PDF)
183Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer
Environmental Research, 2016, 145, 93-100
8.055Citations (PDF)
184Alcohol intake from early adulthood to midlife and mammographic density
Cancer Causes and Control, 2016, 27, 493-502
1.88Citations (PDF)
185Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum0.033Citations (PDF)
186Age at cancer diagnosis, amenability to medical interventions, and racial/ethnic disparities in cancer mortality
Cancer Causes and Control, 2016, 27, 553-560
1.817Citations (PDF)
187Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
Nature Genetics, 2016, 48, 374-386
16.3114Citations (PDF)
188DNA methylation modifies the association between obesity and survival after breast cancer diagnosis2.517Citations (PDF)
189Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.32.517Citations (PDF)
190Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry
Anticancer Research, 2016, 36, 4437-4442
1.226Citations (PDF)
191Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer4.713Citations (PDF)
192An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers5.026Citations (PDF)
193Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ
Breast Journal, 2015, 21, 377-386
1.535Citations (PDF)
194Life course exposure to smoke and early menopause and menopausal transition
Menopause, 2015, 22, 1076-1083
1.935Citations (PDF)
195Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
PLoS ONE, 2015, 10, e0120020
2.532Citations (PDF)
196Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry2.528Citations (PDF)
197Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk5.133Citations (PDF)
198Assessing absolute changes in breast cancer risk due to modifiable risk factors2.59Citations (PDF)
199Global DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active Women
Journal of Cancer, 2015, 6, 548-554
2.78Citations (PDF)
200Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer
Pediatrics, 2015, 136, 927-937
4.112Citations (PDF)
201Polycyclic aromatic hydrocarbon (PAH)–DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study
Cancer Causes and Control, 2015, 26, 1791-1802
1.824Citations (PDF)
202Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry2.521Citations (PDF)
203Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, 2015, 47, 164-171
16.3198Citations (PDF)
204Validation of Family Cancer History Data in High-Risk Families: The Influence of Cancer Site, Ethnicity, Kinship Degree, and Multiple Family Reporters3.622Citations (PDF)
205Genetic polymorphisms in DNA repair and oxidative stress pathways may modify the association between body size and postmenopausal breast cancer
Annals of Epidemiology, 2015, 25, 263-269
1.78Citations (PDF)
206The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry2.520Citations (PDF)
207Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer13.7382Citations (PDF)
208The association of alcohol consumption with mammographic density in a multiethnic urban population
BMC Cancer, 2015, 15,
3.026Citations (PDF)
209Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population‐based follow‐up study on Long Island, New York
Cancer, 2015, 121, 2244-2252
4.428Citations (PDF)
210Polyunsaturated fatty acid interactions and breast cancer incidence: a population-based case-control study on Long Island, New York
Annals of Epidemiology, 2015, 25, 929-935
1.726Citations (PDF)
211The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women
Cancer Causes and Control, 2015, 26, 1393-1403
1.815Citations (PDF)
212Re: "Quantile Regression--Opportunities and Challenges From a User's Perspective"3.67Citations (PDF)
213Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity0.112Citations (PDF)
214Differences in DNA methylation by extent of breast cancer family history in unaffected women
Epigenetics, 2014, 9, 243-248
3.322Citations (PDF)
215Correlations in global DNA methylation measures in peripheral blood mononuclear cells and granulocytes
Epigenetics, 2014, 9, 1504-1510
3.316Citations (PDF)
216No effect of weight loss on LINE‐1 methylation levels in peripheral blood leukocytes from postmenopausal overweight women
Obesity, 2014, 22, 2091-2096
4.326Citations (PDF)
217Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study
Epigenetics, 2014, 9, 929-933
3.329Citations (PDF)
218C-Reactive Protein and Colorectal Cancer Mortality in U.S. Adults0.930Citations (PDF)
219Early Life Exposure to Cigarette Smoke and Depressive Symptoms Among Women in Midlife
Nicotine and Tobacco Research, 2014, 16, 1298-1306
2.522Citations (PDF)
220Multiple metabolic risk factors and mammographic breast density
Annals of Epidemiology, 2014, 24, 479-483
1.710Citations (PDF)
221Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk4.520Citations (PDF)
222Assessing the goodness of fit of personal risk models
Statistics in Medicine, 2014, 33, 3179-3190
1.79Citations (PDF)
223Changes in mammographic density over time in breast cancer cases and women at high risk for breast cancer
International Journal of Cancer, 2014, 135, 1740-1744
4.538Citations (PDF)
224Mammographic density and serum 25-hydroxyvitamin D levels3.712Citations (PDF)
225Commentary: Towards a definite coherent heterogeneity in meta-analyses5.25Citations (PDF)
226Racial and Gender Discrimination, Early Life Factors, and Chronic Physical Health Conditions in Midlife
Women's Health Issues, 2014, 24, e53-e59
2.115Citations (PDF)
227Human Subjects Protection: An Event Monitoring Committee for Research Studies of Girls From Breast Cancer Families
Journal of Adolescent Health, 2014, 55, 352-357
2.35Citations (PDF)
228Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk
Cancer Causes and Control, 2014, 26, 187-203
1.858Citations (PDF)
229Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence0.980Citations (PDF)
230Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation
Human Genetics, 2013, 132, 523-536
3.120Citations (PDF)
231DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR)
Cancer Causes and Control, 2013, 24, 2157-2168
1.813Citations (PDF)
232Serum Antioxidant Nutrients, Vitamin A, and Mortality in U.S. Adults0.976Citations (PDF)
233Prenatal Exposure to the Pesticide DDT and Hypertension Diagnosed in Women before Age 50: A Longitudinal Birth Cohort Study8.652Citations (PDF)
234Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
PLoS Genetics, 2013, 9, e1003212
3.3215Citations (PDF)
235Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer1.528Citations (PDF)
236Early life socioeconomic factors and genomic DNA methylation in mid-life
Epigenetics, 2013, 8, 23-27
3.370Citations (PDF)
237Incidence Rate of Breast Cancer in Young Women13.76Citations (PDF)
238Hormone Replacement Therapy and Breast Cancer Risk: More Evidence for Risk Stratification?5.14Citations (PDF)
239Diagnostic Chest X-Rays and Breast Cancer Risk before Age 50 Years for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers0.922Citations (PDF)
240Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer
Cancer Causes and Control, 2013, 25, 215-226
1.89Citations (PDF)
241A Nonsynonymous Polymorphism in<i>IRS1</i>Modifies Risk of Developing Breast and Ovarian Cancers in<i>BRCA1</i>and Ovarian Cancer in<i>BRCA2</i>Mutation Carriers0.921Citations (PDF)
242Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer
Cancer Prevention Research, 2012, 5, 1144-1154
1.180Citations (PDF)
243Genomic Methylation Changes Over Time in Peripheral Blood Mononuclear Cell DNA: Differences by Assay Type and Baseline Values0.923Citations (PDF)
244Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry
Epigenetics, 2012, 7, 868-874
3.338Citations (PDF)
245Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i>/<i>2</i> (CIMBA)0.9523Citations (PDF)
246Adult global DNA methylation in relation to pre-natal nutrition5.263Citations (PDF)
247Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry
Carcinogenesis, 2012, 33, 1946-1952
2.959Citations (PDF)
248Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry2.510Citations (PDF)
249Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 502.573Citations (PDF)
250Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival2.538Citations (PDF)
251Ovarian cancer susceptibility alleles and risk of ovarian cancer in<i>BRCA1</i>and<i>BRCA2</i>mutation carriers
Human Mutation, 2012, 33, 690-702
4.131Citations (PDF)
252Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry2.58Citations (PDF)
253DNA methylation in white blood cells
Epigenetics, 2011, 6, 828-837
3.3282Citations (PDF)
254The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study
Epigenetics, 2011, 6, 1276-1283
3.317Citations (PDF)
255Childhood Hair Product Use and Earlier Age at Menarche in a Racially Diverse Study Population: A Pilot Study
Annals of Epidemiology, 2011, 21, 461-465
1.757Citations (PDF)
256STROBE-ME — Illuminating methodological issues for the reporting of molecular epidemiology data
Preventive Medicine, 2011, 53, 388-389
2.92Citations (PDF)
257Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women
Cancer Causes and Control, 2011, 22, 599-610
1.827Citations (PDF)
258Global DNA methylation levels in girls with and without a family history of breast cancer
Epigenetics, 2011, 6, 29-33
3.331Citations (PDF)
259Global methylation profiles in DNA from different blood cell types
Epigenetics, 2011, 6, 76-85
3.3124Citations (PDF)
260The Handling of Missing Data in Molecular Epidemiology Studies0.918Citations (PDF)
261Prenatal Smoke Exposure and Genomic DNA Methylation in a Multiethnic Birth Cohort0.987Citations (PDF)
262Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Human Molecular Genetics, 2011, 20, 4732-4747
3.130Citations (PDF)
263Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers5.136Citations (PDF)
264Racial/Ethnic Differences in Hormonally-Active Hair Product Use: A Plausible Risk Factor for Health Disparities1.5104Citations (PDF)
265Does Stage of Change Modify the Effectiveness of an Educational Intervention to Improve Diet among Family Members of Hospitalized Cardiovascular Disease Patients?1.220Citations (PDF)
266Prenatal and childhood environmental tobacco smoke exposure and age at menarche2.339Citations (PDF)
267Controversies in Communication of Genetic Screening Results for Cancer: A Report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida)0.97Citations (PDF)
268XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study4.125Citations (PDF)
269Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
PLoS Genetics, 2010, 6, e1001183
3.375Citations (PDF)
270Associations between Polycyclic Aromatic Hydrocarbon–Related Exposures and <i>p53</i> Mutations in Breast Tumors8.658Citations (PDF)
271The Impact of Socioeconomic Status across Early Life on Age at Menarche Among a Racially Diverse Population of Girls
Annals of Epidemiology, 2010, 20, 836-842
1.794Citations (PDF)
272Multiple Genetic Variants in Telomere Pathway Genes and Breast Cancer Risk0.946Citations (PDF)
273Validity of Self-reported Birth Weight by Adult Women: Sociodemographic Influences and Implications for Life-Course Studies3.631Citations (PDF)
2743-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
Cancer Research, 2009, 69, 6299-6306
0.6124Citations (PDF)
275Birth Weight, Postnatal Growth, and Age at Menarche3.687Citations (PDF)
276Aberrant Methylation of RASSF1A in Plasma DNA Before Breast Cancer Diagnosis in the Breast Cancer Family Registry0.925Citations (PDF)
277Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk
Cancer Prevention Research, 2009, 2, 598-604
1.1109Citations (PDF)
278Plasma Protein Carbonyls and Breast Cancer Risk in Sisters Discordant for Breast Cancer from the New York Site of the Breast Cancer Family Registry
Cancer Research, 2009, 69, 2966-2972
0.630Citations (PDF)
279Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Human Molecular Genetics, 2009, 18, 4442-4456
3.190Citations (PDF)
280Antidepressant Medications and Change in Mammographic Density in Postmenopausal Women0.93Citations (PDF)
281Medical Advances and Racial/Ethnic Disparities in Cancer Survival0.9112Citations (PDF)
282Mutations in <i>p53</i>, p53 protein overexpression and breast cancer survival4.135Citations (PDF)
283Telomere length, oxidative damage, antioxidants and breast cancer risk
International Journal of Cancer, 2009, 124, 1637-1643
4.5132Citations (PDF)
284Prevalence and predictors of antioxidant supplement use during breast cancer treatment
Cancer, 2009, 115, 3271-3282
4.439Citations (PDF)
285Alcohol intake over the life course and mammographic density2.537Citations (PDF)
286Life course socioeconomic conditions, passive tobacco exposures and cigarette smoking in a multiethnic birth cohort of U.S. women
Cancer Causes and Control, 2009, 20, 867-876
1.827Citations (PDF)
287The role of birth cohorts in studies of adult health: the New York women's birth cohort2.324Citations (PDF)
288An International Case-Control Study of Adult Diet and Brain Tumor Risk: A Histology-Specific Analysis by Food Group
Annals of Epidemiology, 2009, 19, 161-171
1.751Citations (PDF)
289Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk
European Journal of Cancer, 2008, 44, 710-717
3.316Citations (PDF)
290Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR
Carcinogenesis, 2008, 29, 1367-1372
2.932Citations (PDF)
291Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women0.915Citations (PDF)
292Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project
Carcinogenesis, 2008, 29, 766-771
2.922Citations (PDF)
293Genomic DNA Methylation among Women in a Multiethnic New York City Birth Cohort0.9151Citations (PDF)
294BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research2.552Citations (PDF)
295Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression
Cancer Causes and Control, 2008, 20, 361-368
1.832Citations (PDF)
296Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk
Carcinogenesis, 2007, 28, 2548-2551
2.947Citations (PDF)
297Age and Menopausal Effects of Hormonal Birth Control and Hormone Replacement Therapy in Relation to Breast Cancer Risk
American Journal of Epidemiology, 2007, 165, 1187-1198
3.640Citations (PDF)
298Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk0.976Citations (PDF)
299Short Telomere Length and Breast Cancer Risk: A Study in Sister Sets
Cancer Research, 2007, 67, 5538-5544
0.6126Citations (PDF)
300Maternal, Birth, and Early-Life Influences on Adult Body Size in Women3.658Citations (PDF)
301Preeclampsia, Pregnancy-related Hypertension, and Breast Cancer Risk
American Journal of Epidemiology, 2007, 165, 1007-1014
3.639Citations (PDF)
302Genetic polymorphisms in alcohol metabolism, alcohol intake and the risk of stomach cancer in Warsaw, Poland
International Journal of Cancer, 2007, 121, 2060-2064
4.533Citations (PDF)
303Plasma protein carbonyl levels and breast cancer risk4.148Citations (PDF)
304Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry2.522Citations (PDF)
305Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas
Cancer Causes and Control, 2007, 18, 1039-1046
1.826Citations (PDF)
306Lifetime Alcohol Intake and Breast Cancer Risk
Annals of Epidemiology, 2006, 16, 230-240
1.798Citations (PDF)
307RE: Selection and Recall Bias in a Case-Control Study of Lifetime Alcohol Intake and Breast Cancer Risk
Annals of Epidemiology, 2006, 16, 920-921
1.70Citations (PDF)
308IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH–DNA adducts to breast cancer risk2.513Citations (PDF)
309Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York2.519Citations (PDF)
310Influence of Nativity Status on Breast Cancer Risk Among US Black Women
Journal of Urban Health, 2006, 83, 211-220
3.417Citations (PDF)
311No Increased Risk of Breast Cancer Associated with Alcohol Consumption among Carriers of <i>BRCA1</i> and <i>BRCA2</i> Mutations Ages &amp;lt;50 Years0.938Citations (PDF)
312IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project
Carcinogenesis, 2006, 27, 758-765
2.953Citations (PDF)
313Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk
Carcinogenesis, 2006, 27, 1876-1882
2.939Citations (PDF)
314ADH3 genotype, alcohol intake and breast cancer risk
Carcinogenesis, 2006, 27, 840-847
2.956Citations (PDF)
315Polymorphisms in Nucleotide Excision Repair Genes and DNA Repair Capacity Phenotype in Sisters Discordant for Breast Cancer0.970Citations (PDF)
316Reproductive factors and breast cancer risk among older women2.560Citations (PDF)
317Alcohol consumption and serum hormone levels during pregnancy
Alcohol, 2005, 36, 47-53
0.913Citations (PDF)
318Associations between Breast Cancer Risk and the Catalase Genotype, Fruit and Vegetable Consumption, and Supplement Use3.6122Citations (PDF)
319MnSOD Val-9Ala Genotype, Pro- and Anti-oxidant Environmental Modifiers, and Breast Cancer Among Women on Long Island, New York
Cancer Causes and Control, 2005, 16, 1225-1234
1.838Citations (PDF)
320One-Carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer
Cancer Research, 2005, 65, 1606-1614
0.6142Citations (PDF)
321DNA Repair Capacity of Lymphoblastoid Cell Lines From Sisters Discordant for Breast Cancer5.174Citations (PDF)
322Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk0.982Citations (PDF)
323MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk
Carcinogenesis, 2005, 26, 2131-2137
2.950Citations (PDF)
324Body Size Changes in Relation to Postmenopausal Breast Cancer among Women on Long Island, New York3.677Citations (PDF)
325Birth Weight and Breast Cancer25.55Citations (PDF)
326HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation
Cancer Research, 2005, 65, 9659-9669
0.657Citations (PDF)
327Polycyclic Aromatic Hydrocarbon–DNA Adducts and Breast Cancer: A Pooled Analysis0.183Citations (PDF)
328Association of Frequency and Duration of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk13.7230Citations (PDF)
329Myeloperoxidase Genotype, Fruit and Vegetable Consumption, and Breast Cancer Risk
Cancer Research, 2004, 64, 7634-7639
0.675Citations (PDF)
330Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia
BMC Cancer, 2003, 3,
3.014Citations (PDF)
331Genetic analysis identifies putative tumor suppressor sites at 2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer progression
Oncogene, 2003, 22, 3489-3499
6.662Citations (PDF)
332A conception-to-death cohort
Lancet, The, 2003, 361, 797-798
35.317Citations (PDF)
333Temporal Trends in Tuberculosis Hospitalization Rates Before and After Implementation of Directly Observed Therapy: New York City, 1988–19952.34Citations (PDF)
334The epidemiology of gastric cancer3.1144Citations (PDF)
335Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer2.119Citations (PDF)
336The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer2.5185Citations (PDF)
337Commentary: The impact of fetal and infant exposures along the life course5.226Citations (PDF)
338The birth cohorts grow up: new opportunities for epidemiology2.318Citations (PDF)
339Risk Factors for a Causal Intermediate and an Endpoint: Reconciling Differences3.617Citations (PDF)
340Immunohistochemical analysis of polycyclic aromatic hydrocarbon-DNA adducts in breast tumor tissue
Cancer Letters, 2000, 154, 143-149
8.523Citations (PDF)
341THE AUTHORS REPLY3.60Citations (PDF)
342THE AUTHORS REPLY3.60Citations (PDF)
343Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men
Prostate, 1999, 40, 172-177
2.262Citations (PDF)
344Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas
Oncogene, 1998, 17, 123-127
6.692Citations (PDF)
345Accuracy of Self-Report of Breast Implants2.01Citations (PDF)
346Better preservation of immune function after laparoscopic-assisted vs. open bowel resection in a murine model1.8117Citations (PDF)
347Leisure and occupational physical activity and risk of colorectal adenomatous polyps
1996, 68, 744-748
31Citations (PDF)
348Abortion and the risk of breast cancer: A case-control study in Greece4.51Citations (PDF)